Tymlos

Active Ingredient(s): Abaloparatide
FDA Approved: * April 28, 2017
Pharm Company: * RADIUS HEALTH INC
Category: Osteoporosis

Abaloparatide (brand name Tymlos) is a parathyroid hormone-related protein (PTHrP) analog drug used to treat osteoporosis. Like the related drug teriparatide, it is an anabolic (i.e., bone growing) agent.[1] In 2017, it was approved to treat postmenopausal osteoporosis in the United States. Contents 1 Medical uses 2 Side effects 3 Pharmacology 4 History 4.1 Preclinical studies 4.2 Clinical Trials 5 Commercialization 5.1 Regulatory Information 5.2 Intellectual Property ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
3 Discussions

Dosage List

Tymlos 2000 ug/ml Subcutaneous Injection, Solution
NDC: 70539-001
Labeler:
Radius Health, Inc.

Popular Topics

Tymlos - the new approved drug

I have been prescribed Tymlos but my insurance denied me. I'm in the appeal process and my dr. says we could start R...

4 REPLIES
Tymlos and Blood Sugar

I have been on Tymlos for 12 months. Over the last few months I am having problems with high blood sugars and a high A1C...

2 REPLIES
Cost and Efficacy of Tymlos

Does anyone have coverage for Tymlos? Is there any way to be able to afford the cost? Has anyone felt they have benefite...

1 REPLY